Abstract: The present invention is directed to crystals of ER&bgr; ligand binding domain complexed with (1) N-(n-butyl)-11-[3,17&bgr;-dihydroxyestra-1,3,5(10)-trien-7&agr;-yl]N-methylundecanamide; estradiol and a peptide comprising the amino acid sequence LXXLL; or 17-epiestriol and a peptide comprising the amino acid sequence LXXLL.
Type:
Grant
Filed:
April 27, 2001
Date of Patent:
November 5, 2002
Assignee:
Kara Bio AB
Inventors:
Jan Ljunggren, Ann-Gerd Thorsell, Owe Engstrom, Tomas Bonn, Mats Carlquist, Andrzeji Brzozowski, Ashley Pike, Roderick Hubbard
Abstract: The application relates to a crystal comprising at least 150 amino acid residues of the estrogen receptor-&bgr; (ER&bgr;) ligand binding domain complexed with a ligand which is an antagonist or a partial agonist.
Type:
Grant
Filed:
February 12, 1999
Date of Patent:
May 8, 2001
Assignee:
Kara Bio AB
Inventors:
Jan Ljunggren, Ann-Gerd Thorsell, Owe Engstrom, Tomas Bonn, Mats Carlquist, Andrzej M. Brzozowski, Ashley C. W. Pike, Roderick E. Hubbard